ZERONDA TYLER (Interim CFO) reported 1 transaction at VYNE THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/2/2026ACC: 0001867033-26-000004
Officer· Interim CFO
Since Jun 2021
-4.01K
Net shares
Net seller
$2.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
4.01K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.01K
Price / share
$0.60
Trade value
$2.39K
% of position
3.9%
3/31/2026
103.80K→99.79K
Total
Net shares
−4.01K
Net value
-$2.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2026 | F · Tax Withholding | −4.01K | $0.60 | $2.39K | 3.9% | 103.80K | 99.79K |
| Total | −4.01K | -$2.39K | ||||||
Derivative Transactions0
No derivative transactions reported